Meridian Bioscience, Inc. announced the appointment of Anthony Bihl III to its Board of Directors, effective immediately. His diagnostics experience began with a broad range of operations and financial roles at Dupont, followed by senior executive roles at Bayer Healthcare’s Diagnostics Division which subsequently led to his becoming CEO of Siemens Medical Solutions Diagnostics, after orchestrating the divestiture to Siemens AG. He joins Meridian’s Board after his retirement in April as CEO and Member of the Board of Managers at Bioventus, LLC. Prior to Bioventus, he served as CEO of American Medical Systems, Inc. Bihl will continue to serve on the boards of Sonendo Inc., Spectral Medical Inc., and the Arthritis Foundation.